| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About | |
Sleep, Fatigue, and Dexamethosone in Children with Leukemia
This study is currently recruiting patients.
| Sponsored by: | National Institute of Nursing Research (NINR) |
|---|---|
| Information provided by: | National Institute of Nursing Research (NINR) |
Purpose
The purpose of this study is to determine the relationship between dexamethosone (steroid) and children’s sleep and fatigue.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Leukemia |
Drug: Dexamethosone |
Phase III |
MedlinePlus related topics: Leukemia, Adult Acute; Leukemia, Adult Chronic; Leukemia, Childhood
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title: Sleep, Fatigue, and Dexamethosone in Childhood Cancer
Expected Total Enrollment: 134
Study start: September 2000;
Study completion: June 2004
Approximately 134 children and adolescents will be enrolled. All children and adolescents will wear a wrist actigraph for two consecutive 5-day study periods. Children and adolescents will have blood drawn 2 times on Day 1 when they are on dexamethosone. Their parents will complete a sleep diary and fatigue questionnaire by telephone on Days 2 and 5 of both study periods.
Eligibility
Ages Eligible for Study: 5 Years - 21 Years, Genders Eligible for Study: Both
Criteria
Location
and Contact
Information
More Information
 | ||||||||||||||
| U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
| National Institutes of Health, Department of Health & Human Services | ||||||||||||||
| Copyright, Privacy, Accessibility, Freedom of Information Act | ||||||||||||||